The largest U.S. chemical maker's net income rose to $964 million, or 79 cents a share, from $550 million, or 46 cents a share, in the same period one year earlier. This beat the Capital IQ consensus estimate of 71 cents a share. Revenue increased 0.5% to $14.46 billion, which came up short of the consensus estimate of $14.72 billion.
Adjusted EBITDA margin expanded more than 60 basis points year over year to 16.6%.
The stock was up 1.2% to $49.53 at 11:45 a.m. on Wednesday.
Must Read: Warren Buffett's 10 Favorite Growth Stocks
Separately, TheStreet Ratings team rates DOW CHEMICAL as a "buy" with a ratings score of A. TheStreet Ratings Team has this to say about their recommendation:
"We rate DOW CHEMICAL (DOW) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and attractive valuation levels. We feel these strengths outweigh the fact that the company shows low profit margins."